Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions

Details for Australian Patent Application No. 2004252170 (hide)

Owner Biogen Idec MA Inc.

Inventors Glaser, Scott; Hopp, Jennifer; Chinn, Paul; Yang, Tzung-Horng; Braslawsky, Gary R.

Agent Cullens

Pub. Number AU-B-2004252170

PCT Pub. Number WO2005/000898

Priority 60/516,030 30.10.03 US; 60/515,351 28.10.03 US; 60/483,877 27.06.03 US; 60/508,810 03.10.03 US

Filing date 28 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 27 January 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/000898 Priority application(s): WO2005/000898

27 January 2011 Application Accepted

  Published as AU-B-2004252170

21 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

28 April 2011 Corrigenda

  Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2004 Delete all reference to Application No. 2004252170.

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004252171-Modified binding molecules comprising connecting peptides

2004252169-Antibodies against interleukin-22 and uses therefor